Secnidazole for treatment of bacterial vaginosis: a systematic review.

ABSTRACT:

Background

Bacterial vaginosis (BV) is one of the common vaginal infections among childbearing women. The usual treatment for BV is metronidazole; hence 30% of women have recurrence within 60 to 90 days after treatment. There are some studies which assessed the effect of secnidazole on BV. The aim of this systematic review was to investigate the effectiveness of secnidazole for treatment of BV.

Methods

The Cochrane Library, MEDLINE (PubMed), Scopus, and Web of Science (all databases from inception till October 28, 2018) were searched. Primary outcomes were clinical cure rate and microbiologic cure rate and the secondary outcomes were adverse events. Data was extracted from eligible studies by two review authors individually and analyzed by RevMan 5.3.

Results

Our sear

SUBMITTER: Abd El Aziz MA 

PROVIDER: S-EPMC6802328 | biostudies-literature | 2019 Oct

REPOSITORIES: biostudies-literature